Michael Kurowski

1.7k citations

65 papers · 1.3k indexed · h-index 20

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Infectious Diseases 43
- HIV/AIDS drug development and treatment 40
- HIV/AIDS Research and Interventions 14
Virology 31
- HIV Research and Treatment 31

Co-authors: Courtney V. Fletcher (3 shared papers)Carlo Federico Perno (3 shared papers)David Back (3 shared papers)Giorgio Gatti (3 shared papers)Rodolphe Garaffo (3 shared papers)Andrew Hill (3 shared papers)Marta Boffito (3 shared papers)Schlomo Staszewski (7 shared papers)
Journals: AIDS (7 papers)Antimicrobial Agents and Chemotherapy (6 papers)Journal of Antimicrobial Chemotherapy (6 papers)Antiviral Therapy (5 papers)European Journal of Clinical Pharmacology (5 papers)
Partner nations: Germany United Kingdom United States

In The Last Decade

Michael Kurowski

64 papers receiving 1.3k citations

Peers

Countries citing papers authored by Michael Kurowski

Since Specialization

Citations

This map shows the geographic impact of Michael Kurowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kurowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kurowski more than expected).

Fields of papers citing papers by Michael Kurowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kurowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kurowski. The network helps show where Michael Kurowski may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Kurowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Kurowski Line = papers co-authored together Michael Kurowski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Therapeutic drug monitoring in HIV infection: current status and future directions AIDS ·David Back, Giorgio Gatti, Courtney V. Fletcher, Rodolphe Garaffo, Richard Haubrich, Richard M. W. Hoetelmans, Michael Kurowski, Andrew Luber, Concepta Merry, Carlo Federico Perno	2002	147
2	Ertapenem Pharmacokinetics and Impact on Intestinal Microflora, in Comparison to Those of Ceftriaxone, after Multiple Dosing in Male and Female Volunteers Antimicrobial Agents and Chemotherapy ·Mathias W. Pletz, M Rau, Jürgen B. Bulitta, A de Roux, Olaf Burkhardt, Guido Kruse, Michael Kurowski, Carl Erik Nord, H. Lode	2004	93
3	Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen AIDS ·Marta Boffito, Michael Kurowski, Guido Kruse, Andrew Hill, Andrew Benzie, Mark Nelson, Graeme Moyle, Brian Gazzard, Anton Pozniak	2004	62
4	Current Status and Future Prospects of Therapeutic Drug Monitoring and Applied Clinical Pharmacology in Antiretroviral Therapy Antiviral Therapy ·Marta Boffito, Edward P. Acosta, David M. Burger, Courtney V. Fletcher, Charles Flexner, Rodolphe Garaffo, Giorgio Gatti, Michael Kurowski, Carlo Federico Perno, Gilles Peytavin, Mario Regazzi, David Back	2005	61
5	Atovaquone Maintenance Therapy Prevents Reactivation of Toxoplasmic Encephalitis in a Murine Model of Reactivated Toxoplasmosis Antimicrobial Agents and Chemotherapy ·Ildikò Rita Dunay, Markus M. Heimesaat, Faris Nadiem Bushrab, Rainer Müller, Hartmut Stocker, Keikawus Arastéh, Michael Kurowski, Rudolf Fitzner, Klaus Borner, Oliver Liesenfeld	2004	57
6	The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C European Journal of Drug Metabolism and Pharmacokinetics ·M. Hümpel, Volker Illi, Waltraud Milius, H. Wendt, Michael Kurowski	1979	50
7	Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children Journal of Antimicrobial Chemotherapy ·Uwe Wintergerst, Florian Hoffmann, Annette Jansson, Gundula Notheis, K Huß, Michael Kurowski, Dylan Burger	2008	48
8	Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ritonavir AIDS ·Christoph Stephan, Nils von Hentig, Irene S. Kourbeti, Brenda Dauer, Manfred Mösch, Thomas A. Lutz, Stephan Klauke, Sebastian Harder, Michael Kurowski, Schlomo Staszewski	2004	45
9	Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery AIDS ·Andrea Gingelmaier, Michael Kurowski, R Kästner, Josef Eberle, Ioannis Mylonas, Bernd H. Belohradsky, Klaus Friese, Thomas Grubert	2006	44
10	Pharmacokinetic and tolerability profile of twice‐daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteers HIV Medicine ·Michael Kurowski, T Sternfeld, Andrew J. Sawyer, Andrew Hill, Christiane Möcklinghoff	2003	44
11	Therapeutic Drug Monitoring and Drug–Drug Interactions Involving Antiretroviral Drugs Antiviral Therapy ·Marta Boffito, Edward P. Acosta, David M. Burger, Courtney V. Fletcher, Charles Flexner, Rodolphe Garaffo, Giorgio Gatti, Michael Kurowski, Carlo Federico Perno, Gilles Peytavin, Mario Regazzi, David Back	2005	44
12	Low‐dose ritonavir moderately enhances nelfinavir exposure Clinical Pharmacology & Therapeutics ·Michael Kurowski, Benoite Kaeser, Anthony Sawyer, M. Popescu, Alexander Mrozikiewicz	2002	42
13	A comparison of the steady‐state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy British Journal of Clinical Pharmacology ·Nils von Hentig, Amina Carlebach, Peter Gute, Gaby Knecht, Stefan Klauke, Maren Rohrbacher, Hartmut Stocker, Michael Kurowski, Sebastian Harder, Schlomo Staszewski, Annette Haberl	2006	34
14	Nevirapine Significantly Reduces the Levels of Racemic Methadone and (R)-Methadone in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy ·Hartmut Stocker, Guido Kruse, P. Kreckel, Christian Herzmann, Keikawus Arastéh, Jörg Claus, Heiko Jessen, Christiane Cordes, B Hintsche, Frank Schlote, Lothar Schneider, Michael Kurowski	2004	34
15	Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration Journal of Antimicrobial Chemotherapy ·Andrea Kunz, Mojca Frank‐Bertoncelj, Kizito Mugenyi, Rose Kabasinguzi, Adam Weidenhammer, Michael Kurowski, Charlotte Kloft, Gundel Harms	2008	31
16	[3H]Etorphine receptor binding in vivo. Small fractional occupancy elicits analgesia. Molecular Pharmacology ·David C. Perry, Jan S. Rosenbaum, Michael Kurowski, Wolfgang Sadée	1982	31
17	Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis Scandinavian Journal of Infectious Diseases ·Markus Bickel, Christoph Stephan, Carsten Rottmann, Amina Carlebach, Anette Haberl, Michael Kurowski, Schlomo Staszewski	2004	30
18	Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir Journal of Antimicrobial Chemotherapy ·Markus Bickel, Evrim Anadol, M. Vogel, Wolf Peter Hofmann, Nils von Hentig, J. Kuetscher, Michael Kurowski, Christian Moench, Tessa Lennemann, Thomas A. Lutz, Wolf O. Bechstein, HR Brodt, JK Rockstroh	2010	27
19	Therapy Failure following Selection of Enfuvirtide‐Resistant HIV‐1 in Cerebrospinal Fluid Clinical Infectious Diseases ·S.F.L. van Lelyveld, Monique Nijhuis, Franky Baatz, Ingeborg Wilting, Walter M. van den Bergh, Michael Kurowski, D. de Jong, A. I. M. Hoepelman, Amj Wensing	2010	26
20	Pharmacokinetics of Saquinavir, Atazanavir, and Ritonavir in a Twice-Daily Boosted Double-Protease Inhibitor Regimen Antimicrobial Agents and Chemotherapy ·Nils von Hentig, Axel H. E. Müller, Carsten Rottmann, Timo Wolf, Thomas A. Lutz, Stephan Klauke, Michael Kurowski, B. Oertel, Brenda Dauer, Sebastian Harder, Schlomo Staszewski	2007	19

About Michael Kurowski

Michael Kurowski is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Pediatrics, Perinatology and Child Health and Hepatology, having authored 65 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (40 papers), HIV Research and Treatment (31 papers), HIV/AIDS Research and Interventions (14 papers), HIV-related health complications and treatments (11 papers), Hepatitis C virus research (10 papers), Pharmacological Effects and Toxicity Studies (8 papers), Inflammatory mediators and NSAID effects (5 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). The work is most often cited by research in Virology (590 citations), Infectious Diseases (863 citations), Emergency Medicine (214 citations), Applied Microbiology and Biotechnology (21 citations) and Molecular Medicine (47 citations). Michael Kurowski has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Courtney V. Fletcher, Carlo Federico Perno, David Back, Giorgio Gatti, Rodolphe Garaffo, Andrew Hill, Marta Boffito, Schlomo Staszewski, Hartmut Stocker and Concepta Merry. Their work appears in journals such as AIDS, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Antiviral Therapy and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact